---
title: 'Long-term outcomes among patients who respond within the first year to nivolumab
  plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients'
date: '2024-11-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39612757/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241130171400&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Clinical response evaluated in the first months of therapy
  is a strong predictor of long-term survival, even in patients with poor prognostic
  ...'
disable_comments: true
---
CONCLUSION: Clinical response evaluated in the first months of therapy is a strong predictor of long-term survival, even in patients with poor prognostic ...